Nocdurna carries a Boxed Warning for hyponatremia.
Treatment appeared to reduce fall risk among older adults.
Study confirms associations between nocturia and older age, female sex, overactive bladder, and diabetes.
More than three-quarters of men with nocturnal polyuria had non-dipping blood pressure compared with less than half of men with other causes of nocturia.
Over 12 weeks of treatment, the mean number of nocturia episodes decreased by 1.1 and 0.9 in men who were and were not bothered by their symptoms, a non-significant difference between groups.
Men experiencing 3 or more nocturia episodes per night had a 43% increased mortality risk in adjusted analyses.
Women in service-related occupations were 40% more likely to complain of nocturia than office workers with easy access to bathrooms.
Men with metabolic syndrome or a smoking history had more than triple the risks for persistent moderate to severe nocturia after TURP.
Nocturnal polyuria risk factors such as sleep apnea and pedal edema were underrepresented in the sample population compared with the general population.
A study found that 28.8% of women in a national database reported getting up 2 or more times per night to urinate.
No significant difference in nocturia risk found in patients with higher and lower sodium intake.
Obese individuals and those with central obesity have 1.4- and 1.7-fold greater odds of urinary incontinence (UI), respectively, and 1.4- and 1.9-fold greater odds of urge UI.
In a study, only 5% of nocturia and nocturnal polyuria were prescribed oral desmopressin.
Clinicians tend to focus on the number of voids, but patients worry more about interrupted sleep.
Two phase 3 placebo-controlled randomized trials show the formulation significantly prolongs the first uninterrupted sleep period and proportion of nights with 1 or fewer nocturic episodes.
Rather intermittent oxygen desaturation was associated with a 3% greater likelihood of nocturia.
More patients taking desmopressin decreased their nightly voiding episodes by half or more.
Clinicians' choice of treatment highly correlated with a diagnosis based on urodynamic studies.
At least half of women using tibial nerve stimulation or pelvic floor muscle training experienced fewer night awakenings, according to a new study.
Metabolic syndrome and smoking are associated with 2.5- and 1.7-fold increased odds of moderate or severe nocturia in men with BPH/LUTS.
In a study, men with sleep disorders were 23% and 27% more likely to report nocturia and daytime LUTS than men without sleep disorders.
At baseline, women reported an average of 3.9 urgency incontinence episodes per day and 1.3 episodes of nocturia per night.
Procedure partially blocks blood flow to the gland and appears to ease the need to urinate.
Overall, men with LUTS showed remarkably poor knowledge about their symptoms.
In a study, severe nocturia predicted increased mortality risk.
Increasing secretion of this hormone may prevent and treat the condition.
Keeping abreast of the most current treatments for idiopathic OAB can lead to improved outcomes and quality of life.
Two studies show significant reduction in number of nocturnal voids for women.
The prevalence and severity of nocturia, or awakening at least once at night to urinate, tends to increase with age.
Moderate nocturia may increase the risk of death among men aged 60 years and older, according to study. Among younger men, it may increase the likelihood of developing coronary heart disease later in life.
Renal and Urology News Articles
- FDA Recalls Drugs Containing Active Ingredient Valsartan
- Correcting Metabolic Acidosis May Preserve Muscle Mass
- Infection Risk Lower in Dialysis Patients With High, Normal Vitamin D
- Urine Cytology May Not Improve Hematuria Evaluation for Bladder Cancer
- Aggressive Therapy Warranted for Gleason 10 Prostate Cancer
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)